The purpose of this study is to determine whether an indocyanine green (ICG) fluorescence imaging system (cBPI) can be used to provide surgeons with information about bone health or bone blood flow. This will help surgeons better understand the healing potential of bone and relative risk of complication. This is important to help surgeons select the most appropriate treatment for severe traumatic injuries and infections.
Study Type
OBSERVATIONAL
Enrollment
10
Patients will be administered FDA approved ICG through intravenous injection and imaged by a FDA approved surgical microscope (Spy Elite) which is 0.5 meter away from the subject. Both ICG fluorescence and the two imaging systems have been used for routine clinical practice for many years. Figure (a) shows the Schematic sketch of the imaging systems. ICG fluorescence imaging utilizes intravenously injected ICG, which is a fluorescent dye that is FDA-approved for clinical use, illuminated with near-infrared light. The ICG dye is indirectly activated and the dynamic fluorescence due to bone perfusion can be captured by a video rate imaging system.
Dartmouth-Hitchcock Medical Center
Lebanon, New Hampshire, United States
RECRUITINGNumber of participants who undergo an unplanned fracture-related reoperation
All unplanned reoperations will be documented using a specific case report form
Time frame: 12 Months
Number of participants who experience a post-procedure surgical site infection
Post-procedure surgical site infection using Centers for Disease Control criteria will be documented at each follow-up
Time frame: 12 Months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.